Cecilia Furlong
Stock Analyst at Morgan Stanley
(1.41)
# 3,528
Out of 5,179 analysts
177
Total ratings
41.33%
Success rate
-3.08%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cecilia Furlong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SGHT Sight Sciences | Maintains: Equal-Weight | $6 → $8 | $3.88 | +106.19% | 18 | Dec 2, 2025 | |
| IRTC iRhythm Holdings | Maintains: Overweight | $195 → $205 | $118.10 | +73.58% | 18 | Dec 2, 2025 | |
| MDT Medtronic | Maintains: Overweight | $107 → $117 | $87.14 | +34.27% | 11 | Nov 19, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $115 → $95 | $88.57 | +7.26% | 12 | May 6, 2025 | |
| ISRG Intuitive Surgical | Upgrades: Overweight | $522 → $650 | $452.66 | +43.60% | 13 | Dec 2, 2024 | |
| EMBC Embecta | Maintains: Underweight | $13 → $12 | $8.57 | +40.02% | 12 | Jul 15, 2024 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $75 → $95 | $99.05 | -4.09% | 12 | Feb 28, 2024 | |
| ALC Alcon | Maintains: Equal-Weight | $78 → $85 | $73.34 | +15.90% | 9 | May 11, 2023 | |
| AORT Artivion | Maintains: Equal-Weight | $14 → $15 | $35.29 | -57.50% | 4 | May 8, 2023 | |
| PODD Insulet | Maintains: Equal-Weight | $325 → $343 | $208.22 | +64.73% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $11 → $14 | $1.17 | +1,096.58% | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $44 → $48 | $15.97 | +200.56% | 4 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $102 | $79.34 | +28.56% | 8 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $56 → $58 | $69.17 | -16.15% | 17 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $20 | $15.37 | +30.12% | 5 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $117 → $131 | $62.25 | +110.44% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $133 | $103.99 | +27.90% | 11 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $270 → $220 | $327.44 | -32.81% | 4 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $383 → $378 | $116.22 | +225.25% | 2 | Feb 25, 2022 |
Sight Sciences
Dec 2, 2025
Maintains: Equal-Weight
Price Target: $6 → $8
Current: $3.88
Upside: +106.19%
iRhythm Holdings
Dec 2, 2025
Maintains: Overweight
Price Target: $195 → $205
Current: $118.10
Upside: +73.58%
Medtronic
Nov 19, 2025
Maintains: Overweight
Price Target: $107 → $117
Current: $87.14
Upside: +34.27%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Equal-Weight
Price Target: $115 → $95
Current: $88.57
Upside: +7.26%
Intuitive Surgical
Dec 2, 2024
Upgrades: Overweight
Price Target: $522 → $650
Current: $452.66
Upside: +43.60%
Embecta
Jul 15, 2024
Maintains: Underweight
Price Target: $13 → $12
Current: $8.57
Upside: +40.02%
TransMedics Group
Feb 28, 2024
Maintains: Equal-Weight
Price Target: $75 → $95
Current: $99.05
Upside: -4.09%
Alcon
May 11, 2023
Maintains: Equal-Weight
Price Target: $78 → $85
Current: $73.34
Upside: +15.90%
Artivion
May 8, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $35.29
Upside: -57.50%
Insulet
May 5, 2023
Maintains: Equal-Weight
Price Target: $325 → $343
Current: $208.22
Upside: +64.73%
May 3, 2023
Maintains: Equal-Weight
Price Target: $11 → $14
Current: $1.17
Upside: +1,096.58%
Apr 28, 2023
Maintains: Equal-Weight
Price Target: $44 → $48
Current: $15.97
Upside: +200.56%
Apr 27, 2023
Maintains: Overweight
Price Target: $95 → $102
Current: $79.34
Upside: +28.56%
Apr 27, 2023
Maintains: Overweight
Price Target: $56 → $58
Current: $69.17
Upside: -16.15%
Feb 23, 2023
Maintains: Equal-Weight
Price Target: $18 → $20
Current: $15.37
Upside: +30.12%
Jan 6, 2023
Maintains: Equal-Weight
Price Target: $117 → $131
Current: $62.25
Upside: +110.44%
Jan 6, 2023
Maintains: Overweight
Price Target: $117 → $133
Current: $103.99
Upside: +27.90%
Jul 15, 2022
Maintains: Equal-Weight
Price Target: $270 → $220
Current: $327.44
Upside: -32.81%
Feb 25, 2022
Maintains: Equal-Weight
Price Target: $383 → $378
Current: $116.22
Upside: +225.25%